Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
REPL

Replimune Group (REPL) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $13.42 +2.9% on the day +189.8% over 12 months 52-week range $1.70 – $15.98

Share price and insider trades

REPL closeInsider buyInsider sale
05101520NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $32,958 on 2025-12-09 · Kapil DhingraSold $52,065 on 2026-04-02 · Christopher SarchiSold $110,880 on 2026-06-01 · Christopher SarchiSold $111,300 on 2025-12-02 · Sushil PatelSold $113,350 on 2025-11-17 · Christopher Sarchi, Konstantinos XynosSold $132,176 on 2026-08-17 · Emily Luisa HillSold $474,147 on 2026-05-18 · Andrew Schwendenman, Christopher Sarchi, Emily Luisa Hill, Konstantinos Xynos, Philip Astley-sparke, Sushil PatelSold $906,188 on 2026-08-10 · Andrew Schwendenman, Emily Luisa Hill, Konstantinos Xynos, Sushil Patel
Bought, 12 months$0
Sold, 12 months$1.9M
Insiders buying0
Insiders selling7

Replimune Group insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 7 sold $1.9M of REPL stock on the open market.

REPL insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $258K sold (4 trades)Q4 2025Q1 2026Q2 2026: $637K sold (8 trades)Q2 2026Q3 2026: $1.0M sold (5 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$1.0M5
Q2 2026—0$637K8
Q1 2026—0—0
Q4 2025—0$258K4

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.5×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 Replimune Group, Inc. insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $1.9M. 3 of 17 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 19SEC Emily Luisa HillCFO Sell 9,256215,852 held (−4%) $14.28 $132K -6.0% —
Aug 12SEC Sushil PatelCEO Sell 39,341708,151 held (−5%) $12.97 $510K +3.5% —
Aug 12SEC Emily Luisa HillCFO Sell 11,448225,108 held (−5%) $12.97 $148K +3.5% —
Aug 12SEC Konstantinos XynosChief Medical Officer Sell 11,447224,215 held (−5%) $12.97 $148K +3.5% —
Aug 12SEC Andrew SchwendenmanChief Accounting Officer Sell 7,63299,425 held (−7%) $12.97 $99K +3.5% —
Jun 3SEC Christopher SarchiChief Commercial Officer Sell Plan 12,000180,962 held (−6%) $9.24 $111K +45.2% —
May 20SEC Sushil PatelCEO Sell 37,324747,492 held (−5%) $5.08 $190K +164.2% —
May 20SEC Philip Astley-sparkeDirector Sell 17,6571,412,414 held (−1%) $5.08 $90K +164.2% —
May 20SEC Konstantinos XynosChief Medical Officer Sell 14,023235,662 held (−6%) $5.08 $71K +164.2% —
May 20SEC Christopher SarchiChief Commercial Officer Sell 8,626192,962 held (−4%) $5.08 $44K +164.2% —
May 20SEC Andrew SchwendenmanChief Accounting Officer Sell 7,894107,057 held (−7%) $5.08 $40K +164.2% —
May 20SEC Emily Luisa HillCFO Sell 7,812236,556 held (−3%) $5.08 $40K +164.2% —
Apr 6SEC Christopher SarchiChief Commercial Officer Sell Plan 6,500151,588 held (−4%) $8.01 $52K +67.5% —
Dec 11SEC Kapil DhingraDirector Sell 3,169 $10.40 $33K +29.0% —
Dec 4SEC Sushil PatelCEO Sell Plan 10,000333,576 held (−3%) $11.13 $111K +20.6% —
Nov 19SEC Konstantinos XynosChief Medical Officer Sell 7,248139,685 held (−5%) $9.10 $66K +47.5% —
Nov 19SEC Christopher SarchiChief Commercial Officer Sell 5,208123,088 held (−4%) $9.10 $47K +47.5% —

Insiders at Replimune Group, Inc.

InsiderBoughtSoldLast filingScore
Sushil PatelCEO — $811K Aug 12, 2026 —
Emily Luisa HillCFO — $320K Aug 19, 2026 —
Konstantinos XynosChief Medical Officer — $286K Aug 12, 2026 —
Christopher SarchiChief Commercial Officer — $254K Jun 3, 2026 —
Andrew SchwendenmanChief Accounting Officer — $139K Aug 12, 2026 —
Philip Astley-sparkeDirector — $90K May 20, 2026 —
Kapil DhingraDirector — $33K Dec 11, 2025 —

REPL stock: common questions

Are Replimune Group, Inc. insiders buying REPL stock?

In the past 12 months, 0 insiders reported open-market purchases of REPL worth $0.

Are Replimune Group, Inc. insiders selling REPL stock?

7 insiders reported sales worth $1.9M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is REPL's 52-week range?

Over the past year REPL has traded between $1.70 and $15.98. It last closed at $13.42 on Oct 9, 2026.